Plus   Neg

Stock Alert: Acorda Therapeutics Gains 50% On Plan To Sell INBRIJA

Acorda Therapeutics, Inc. (ACOR) shares are rising on Wednesday morning trade as the company announced an agreement to sell INBRIJA manufacturing operations in Chelsea, Massachusetts to Catalent for $80 million in cash.

Currently, the shares are at $6.37, up 50.20 percent from the previous close of $4.24 on a volume of 13,012,552. For the 52-week period, the shares have traded in range of $2.52 to $15.30 on average volume of 840,684. The shares have been bullish since December first week.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT